Investigating the potential of prebiotics to rebalance and maintain health
Task Force Information
Objectives
The Prebiotics Task Force advances understanding of how prebiotics interact with the gut microbiota and influence human health, moving from observed benefits towards clear biological mechanisms.
Why It Matters
For public health, stronger mechanistic evidence supports evidence-based strategies that protect consumers and help people make informed choices about products intended to support health.
For companies, mechanistic evidence helps guide product innovation, identify effective prebiotic solutions and strengthen scientific substantiation of health benefits.
Task Force Members
| Clémentine Thabuis-Chair | Roquette | Senior Nutrition and Health Research Manager | FR |
| Elaine Vaughan-Vice-Chair | Cosun | Health Science & Regulatory Affairs | NL |
| Kristin Verbeke, Co-Chair* | Translational Research Center for Gastrointestinal Disorders (TARGID) | Researcher | BE |
| Paul de Vos* | Centre for Healthy Eating & Food Innovation (HEFI), Maastricht University) | Professor | NL |
| Aurélie Goux | Cargill | Senior Scientist in Nutrition and Health | BE |
| Jessica Van Harsselaar | Südzucker Group | Manager Nutrition Science | DE |
| Georgina Dodd | Clasado | R&D Senior Scientist | UK |
| Sofia Forssten | IFF | Lead Scientist | FI |
| Damien Guillemet | Nexira | Scientific Development Director | FR |
| Alexandra Meynier | Mondelez International | Nutrition Scientist | FR |
| Robert Steinert | DSM-Firmenich | Principal Scientist | DK |
| Bernd Stahl | Danone Nutricia | Associate Professor | NL |
*Scientific Advisor
For more detailed information, please contact Léonie Lang at llang@ilsieurope.be
Activity Overview
Ongoing
- Markers of the Gut Microbiota
The group aims to identify key markers for assessing microbiota improvement, focusing on measurable indicators of microbiota composition. The activity is shared with the Probiotics Task Force.
Start date: 2024 - End date: 2026
- Role of Prebiotics in Better Managing Women’s Health
The Expert Group will aim to understand the extent and mechanisms by which prebiotics impact the women’s health in different stages of life.
Start date: 2025 - End date: 2027
- Shaping Metabolic Health: GLP-1 Receptor Agonists, Prebiotics, and the Gut-Brain Axis
The research group will explore how prebiotics support weight control, both independently and alongside GLP-1 receptor agonists. A workshop on GLP-1 analogues and health outcomes is planned for Q1 2026. The Expert Group will investigate key mechanisms, such as SCFA production, gut hormone stimulation, and microbiome modulation—with a focus on enhancing satiety, metabolic regulation, and treatment adherence. A key objective is to evaluate whether prebiotics can help reduce GLP-1–related side effects, such as gastrointestinal discomfort.
Start Date: 2026 - End Date: 2028
In the Pipeline
In 2027, the Task Force will develop a new activity proposal.
While the exact scope is still to be defined, prioritised topics include:
- Interindividual variability in response to prebiotics: prebiotics and specific place of fermentation (from small intestine to distal colon);
- Consumer interest and understanding of fibers and prebiotics: the role of prebiotics in GLP1-RA users and ex-users.
Expert Groups
Markers of the Gut Microbiota
Background and Objectives
Changes in the gut microbiota are increasingly linked to health outcomes, but consistent markers for measuring these effects are still lacking. This Expert Group aims to establish standardized markers for assessing improvements in gut microbiota composition and activity following dietary interventions. They will evaluate microbial composition, metabolites, enzymatic systems, mucosal integrity and immune responses to identify the most informative and predictive parameters for human health and strengthen the evidence linking prebiotic-induced microbiota changes to health benefits.
Output
Open-access peer-reviewed publication.
Expert Group Members
| Sahar El Aidy - Chair | University of Amsterdam | NL |
| Renate Akkerman | Maastricht University | NL |
| Paul de Vos | Maastricht University | NL |
| Kristin Verbeke | KU Leuven | BE |
| Anisha Wijeyesekera | University of Reading | UK |
| Jonathan Swann | University of Southampton | UK |
| Sofia Forssten | IFF | FI |
| Damien Guillemet | Nexira | FR |
| Alexandra Meynier | Mondelez | FR |
| Clémentine Thabuis | Roquette | FR |
| Delphine Saulnier | Novonesis | DK |
| Holly Sedgwick | University of Reading | UK |
Role of Prebiotics in Better Managing Women’s Health
Background and Objectives
Women’s health is shaped by complex interactions between the microbiome, immune system, metabolism and hormonal changes across the life course. This Expert Group aims to assess how prebiotics may support women’s health from puberty through reproductive years, pregnancy, menopause and ageing. They will review current evidence on prebiotic interventions and health outcomes, examine underlying mechanisms including microbial composition, metabolites, barrier function, immune regulation and estrogen metabolism, and identify key research gaps to guide more inclusive and hormone-informed future studies.
Output
Open-access peer-reviewed publication
Expert Group Members
| Clementine Thabuis | Roquette | FR |
| David Vauzour | University of East Anglia | UK |
| Verlee Dam | Cosun | Nl |
| Georgina Dodd | Clasado | UK |
| Isabel Erreygers | University of Antwerp | BE |
| Paul de Vos | Maastricht University | NL |
| Reeta Ala Jaakkola | IFF | FI |
| Samira Prado | Örebro University | SE |
| Sarah Lebeer | University of Antwerp | BE |
| Siobhain O'Mahony | University College Cork | IE |
Shaping Metabolic Health: GLP-1 Receptor Agostist, Prebiotics, and the Gut-Brain Axis
Background and Objectives
Metabolic, cognitive and mental health are increasingly linked to interactions between the gut, brain and metabolic signalling pathways. This workshop explored how GLP-1 receptor agonists and prebiotic strategies may influence appetite regulation, metabolic health, cognition and mental well-being through the gut–brain axis. Experts reviewed emerging evidence, discussed real-world clinical implications, and identified key knowledge gaps and priority research questions to guide future collaborative research.
Output
Open-access peer-reviewed publication.
Expert Group Members
Publications
Z to A
Towards Microbial Fermentation Metabolites as Markers for Health Benefits of Prebiotics
2015
The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice
Cellular and Molecular Life Sciences, 2022
(2022) 79:80. Commissioned by the Early Nutrition and Long-Term Health, Nutrition and Brain Health, Nutrition, Immunity and Inflammation, Prebiotics and Probiotics Task Forces.
Targeting cognitive resilience through prebiotics: A focused perspective
Advances in Nutrition, 2024
This perspective article is a product of the work of an expert group within the Prebiotic Task Force convened by the International Life Sciences Institute Europe (ILSI Europe), a non-profit organization that brings together experts from academia, industry and public service to catalyse nutrition science for public benefit.
Systematic Review of the Effects of the Intestinal Microbiota on Selected Nutrients and Non-Nutrients
2017
European Journal of Nutrition 2018;57(1):25-49. Commissioned by the Functional Foods and the Prebiotics Task Forces.
Structure and function of non-digestible carbohydrates in the gut microbiome
Beneficial Microbes, 2022
Commissioned by the Prebiotics Task Force.
Multimedia
Completed Expert Groups
Overview of completed activities
- Role of prebiotics in bacterial and viral infection, and vaccination efficiency
- “Prebiotics Sandpit” Workshop: Identifiyng Knowledge Gaps and a Roadmap for Building an Health Claims Portfolio
- Role of prebiotics in cognitive functioning: What do we know and where to go next?
- Prediction of individual responses to prebiotics and probiotics intervention (collaboration with Probiotics Task Force)
- Understanding the Relationship Between the Molecular Structure and the Effects of Prebiotic Compounds on Microbiota and its Metabolites
- Joint nutrition cluster activity on ‘mechanistic insights into the gut-brain axis' in collaboration with Early Nutrition and Long-Term Health; Health Benefit Assessment of Foods; Nutrition, Immunity & Inflammation; Nutrition & Brain Health; and Probiotics Task Forces
- Updated concise monograph - Dietary Probiotics, Prebiotics and the Gut Microbiota in Human Health (collaboration with Probiotics Task Force)
- Revealing the Mechanistic Role in Human Physiology and Beneficial Aspects of Short Chain Fatty Acid (SCFA) Production in the Gastro-Intestinal Tract (GIT)